Vascular Dementia Trials
Oct 23, 2026
Vascular Dementia Treatment Space: A Billion-Dollar Gap Waiting for Its First Approved Drug
Summary Vascular dementia is the second most common form of dementia after Alzheimer’s disease; however, no drug has been specifically approved for its treatment. In 2025, the total number of diagnosed prevalent cases of vascular dementia across the seven major markets was estimated at 3 million, with ...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
